SK Current, beta-3 adrenoceptor activation and Sex Differences in Ventricular Arrhythmogenesis
SK 电流、β3 肾上腺素受体激活和室性心律失常发生的性别差异
基本信息
- 批准号:10734708
- 负责人:
- 金额:$ 59.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-12-15 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcetylcholineAction PotentialsAdrenergic AgentsAdrenergic ReceptorAgonistAnti-Arrhythmia AgentsApaminArrhythmiaArteriesAtrioventricular BlockAutonomic nervous systemBrainBuffersCardiacCatecholaminesCellsCharybdotoxinChemicalsComputer SimulationCoronaryDiseaseElectric CountershockEmbryoEndotheliumFDA approvedFemaleFundingGoalsHeartHeart AtriumHumanInfusion proceduresIsoproterenolLeftMapsMediatingMessenger RNAModelingMyocardial InfarctionMyocardiumNa(+)-K(+)-Exchanging ATPaseNerveNerve Growth FactorsNeuronsNitric Oxide SynthaseOpticsOryctolagus cuniculusOuabainOveractive BladderPatientsPharmaceutical PreparationsPhasePlayProteinsRecurrenceRelaxationReportingResearch Project GrantsResistanceRoleSex DifferencesShockStructure of stellate ganglionSudden DeathSyndromeTestingTranslationsVasodilationVentricularVentricular ArrhythmiaVentricular FibrillationVentricular Tachycardiaantagonistbeta-2 Adrenergic Receptorscanine modelclinically significantexperimental studyheart rhythmindium arsenidekidney cellmalepatch clampresponsesudden cardiac death
项目摘要
Project Summary
The broad and long-term goal of this research project is to test the hypothesis that (1) the response of apamin-
sensitive small conductance Ca2+-activated K+ (SK) current (IKAS) to sympathetic stimulation plays an important
role in the mechanisms of sex differences in cardiac arrhythmogenesis and that (2) beta-3 adrenoceptor (AR)
activation is antiarrhythmic and eliminates the sex difference of IKAS activation during sympathetic stimulation.
In the current funding period, we discovered a significant sex difference of both the SK protein and IKAS at
baseline and that the magnitudes of sex differences are amplified during isoproterenol or acetylcholine
infusion. Apamin reduces the phase singularities (PSs) in ventricular fibrillation (VF) more effectively in the
female than in the male ventricles. It is unclear which AR is responsible for the isoproterenol-induced IKAS
activation. Isoproterenol activates the beta-1 and beta-2 ARs at lower concentrations than the beta-3 AR.
Contrary to the effects of beta-1 and beta-2 AR activation, beta-3 AR activation exerts negative inotropic
effects in the myocardium. Beta-3 ARs likely served as a buffer or rescuer of the excess catecholamines. We
showed in a canine model of ventricular tachycardia that BRL-37344 (a beta-3 agonist) is antiarrhythmic. We
hypothesize that beta-3 AR activation is antiarrhythmic and eliminates the sex difference of IKAS activation
during sympathetic stimulation in the rabbit model. Specific Aim 1: SK current, beta-3 adrenoceptor activation,
and Sex Differences in Ventricular Arrhythmogenesis. We will perform optical mapping and patch clamp
studies with specific beta-1 and beta-2 antagonists in the presence of isoproterenol. We also will perform
optical mapping studies to determine the effects of mirabegron on phase singularities (PSs) during VF with and
without isoproterenol. In additional experiments, we will use BRL-37344 instead of mirabegron to test the
hypothesis that this antiarrhythmic mechanism is a class effect shared by other beta-3 agonists. The
antiarrhythmic action of mirabegron will then be tested in a rabbit model of myocardial infarction. These
findings will be used to test the hypothesis that beta-3 AR activation rescues the proarrhythmic effects of beta-
1 and beta-2 stimulation, indirectly reduce IKAS, and eliminates the sex differences of PSs in VF. Specific Aim 2:
Na+-K+ ATPase (NKA) activation during beta3 stimulation contributes to the sex differences of antiarrhythmic
action. Beta-3 AR activates NKA, which may reduce Ca2+ overload-induced cardiac arrhythmias. We
hypothesize that NKA activation plays a vital role in the antiarrhythmic effects of beta-3 AR activation. We will
first perform studies to determine if there is a sex difference in beta-3 AR, NKA protein, and mRNA in rabbit
ventricles. Optical mapping studies will be done in the presence of ouabain, a specific NKA blocker, to
determine if the company of NKA is required for the antiarrhythmic effects of beta-3 activation. Rabbit
ventricular action potential models will be used for computer simulation studies to assess the importance of
NKA activation in the antiarrhythmic mechanisms of beta-3 AR activation.
项目摘要
这项研究项目的广泛和长期目标是检验以下假设:(1)阿帕明的反应-
对交感神经刺激敏感的小电导钙激活钾电流(IKAS)起重要作用
性别差异在心律失常发生机制中的作用及(2)β-3肾上腺素能受体
激活是抗心律失常的,并消除交感神经刺激时IKAS激活的性别差异。
在当前的资助期间,我们发现SK蛋白和IKAS在
在异丙肾上腺素或乙酰胆碱期间,性别差异的大小被放大
输液。阿帕明能更有效地减少室颤(VF)的相位奇异性(PSS)。
女性多于男性脑室。目前还不清楚哪种AR对异丙肾上腺素诱导的IKAS负责
激活。异丙肾上腺素在比β-3受体浓度低的情况下激活β-1和β2受体。
与β-1和β-2受体激活的作用相反,β-3受体激活发挥负性肌力作用
对心肌的影响。β-3受体可能是过量儿茶酚胺的缓冲器或救援者。我们
在犬室性心动过速的模型中显示,BRL-37344(一种β-3激动剂)具有抗心律失常的作用。我们
假设β-3受体的激活是抗心律失常的,并消除了IKAS激活的性别差异
在兔模型的交感神经刺激过程中。具体目标1:SK电流,β-3肾上腺素能受体激活,
室性心律失常的性别差异。我们将进行光学标测和膜片钳
在异丙肾上腺素存在的情况下对特定的β-1和β-2拮抗剂的研究。我们还将表演
光学标测研究,以确定米雷贝格隆对VF期间位相奇点(PSS)的影响
不含异丙肾上腺素。在其他实验中,我们将使用BRL-37344代替Mirabegron来测试
假设这种抗心律失常机制是其他β-3激动剂共有的一类效应。这个
然后将在兔心肌梗死模型上测试米拉贝格隆的抗心律失常作用。这些
研究结果将被用来检验这一假说,即β-3受体激活挽救了β-3受体促心律失常的作用。
刺激1和β2,间接减少IKAS,消除室颤患者PSS的性别差异。具体目标2:
β3刺激下Na+-K+-ATPase(NKA)的激活与抗心律失常药物的性别差异
行动。β-3受体可激活NKA,从而减轻钙超载所致的心律失常。我们
假设NKA激活在β-3受体激活的抗心律失常作用中起重要作用。我们会
首先进行研究以确定兔的β-3AR、NKA蛋白和mRNA是否存在性别差异
脑室。光学映射研究将在哇巴因存在的情况下进行,哇巴因是一种特定的NKA阻滞剂,以
确定是否需要NKA公司来发挥β-3激活的抗心律失常作用。兔子
将使用心室动作电位模型进行计算机模拟研究,以评估
Nka激活在β-3受体激活抗心律失常机制中的作用
项目成果
期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Modeling Calcium Cycling in the Heart: Progress, Pitfalls, and Challenges.
- DOI:10.3390/biom12111686
- 发表时间:2022-11-14
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
Role of apamin-sensitive small conductance calcium-activated potassium currents in long-term cardiac memory in rabbits.
- DOI:10.1016/j.hrthm.2018.01.016
- 发表时间:2018-05
- 期刊:
- 影响因子:5.5
- 作者:Yin D;Chen M;Yang N;Wu AZ;Xu D;Tsai WC;Yuan Y;Tian Z;Chan YH;Shen C;Chen Z;Lin SF;Weiss JN;Chen PS;Everett TH 4th
- 通讯作者:Everett TH 4th
Skin sympathetic nerve activity as a biomarker of fitness.
- DOI:10.1016/j.hrthm.2021.08.031
- 发表时间:2021-12
- 期刊:
- 影响因子:5.5
- 作者:Liu X;Kumar A;O'Neil J;Wong J;Saadoon O;Kadire S;Mitscher GA;Li X;Chen PS;Emery MS;Everett TH 4th
- 通讯作者:Everett TH 4th
Bistable nerve conduction.
- DOI:10.1016/j.bpj.2022.08.006
- 发表时间:2022-09-20
- 期刊:
- 影响因子:3.4
- 作者:Zhang, Zhaoyang;Qu, Zhilin
- 通讯作者:Qu, Zhilin
Why Is Propranolol Better Than Metoprolol in Acute Treatment of Electrical Storm?
为什么普萘洛尔在电风暴的急性治疗中比美托洛尔更好?
- DOI:10.1016/j.jacc.2018.02.058
- 发表时间:2018
- 期刊:
- 影响因子:24
- 作者:Chen,Peng-Sheng;Doytchinova,Anisiia
- 通讯作者:Doytchinova,Anisiia
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PENG-SHENG CHEN其他文献
PENG-SHENG CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PENG-SHENG CHEN', 18)}}的其他基金
Using electrical nerve stimulation to control atrial fibrillation
使用电神经刺激来控制心房颤动
- 批准号:
10397354 - 财政年份:2020
- 资助金额:
$ 59.43万 - 项目类别:
Using electrical nerve stimulation to control atrial fibrillation.
使用电神经刺激来控制心房颤动。
- 批准号:
9807603 - 财政年份:2019
- 资助金额:
$ 59.43万 - 项目类别:
Subcutaneous nerve stimulation for arrhythmia control.
皮下神经刺激可控制心律失常。
- 批准号:
9405146 - 财政年份:2017
- 资助金额:
$ 59.43万 - 项目类别:
Autonomic Nerve Activity and Paroxysmal Atrial Fibrillation
自主神经活动与阵发性心房颤动
- 批准号:
7822294 - 财政年份:2009
- 资助金额:
$ 59.43万 - 项目类别:
WAVE DYNAMICS IN NORMAL AND DISEASED RABBIT HEARTS
正常和患病兔心脏中的波动力学
- 批准号:
7108467 - 财政年份:2005
- 资助金额:
$ 59.43万 - 项目类别:
相似海外基金
Kilohertz volumetric imaging of neuronal action potentials in awake behaving mice
清醒行为小鼠神经元动作电位的千赫兹体积成像
- 批准号:
10515267 - 财政年份:2022
- 资助金额:
$ 59.43万 - 项目类别:
Signal processing in horizontal cells of the mammalian retina – coding of visual information by calcium and sodium action potentials
哺乳动物视网膜水平细胞的信号处理 â 通过钙和钠动作电位编码视觉信息
- 批准号:
422915148 - 财政年份:2019
- 资助金额:
$ 59.43万 - 项目类别:
Research Grants
CAREER: Resolving action potentials and high-density neural signals from the surface of the brain
职业:解析来自大脑表面的动作电位和高密度神经信号
- 批准号:
1752274 - 财政年份:2018
- 资助金额:
$ 59.43万 - 项目类别:
Continuing Grant
Development of Nanosheet-Based Wireless Probes for Multi-Simultaneous Monitoring of Action Potentials and Neurotransmitters
开发基于纳米片的无线探针,用于同时监测动作电位和神经递质
- 批准号:
18H03539 - 财政年份:2018
- 资助金额:
$ 59.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Population Imaging of Action Potentials by Novel Two-Photon Microscopes and Genetically Encoded Voltage Indicators
通过新型双光子显微镜和基因编码电压指示器对动作电位进行群体成像
- 批准号:
9588470 - 财政年份:2018
- 资助金额:
$ 59.43万 - 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
- 批准号:
10009724 - 财政年份:2018
- 资助金额:
$ 59.43万 - 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
- 批准号:
10467225 - 财政年份:2018
- 资助金额:
$ 59.43万 - 项目类别:
Fast high-resolution deep photoacoustic tomography of action potentials in brains
大脑动作电位的快速高分辨率深度光声断层扫描
- 批准号:
9423398 - 财政年份:2017
- 资助金额:
$ 59.43万 - 项目类别:
Noval regulatory mechanisms of axonal action potentials
轴突动作电位的新调节机制
- 批准号:
16K07006 - 财政年份:2016
- 资助金额:
$ 59.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NeuroGrid: a scalable system for large-scale recording of action potentials from the brain surface
NeuroGrid:用于大规模记录大脑表面动作电位的可扩展系统
- 批准号:
9357409 - 财政年份:2016
- 资助金额:
$ 59.43万 - 项目类别: